Antrodia camphorata Supplementation during Early Life Alters Gut Microbiota and Inhibits Young-Onset Intestinal Tumorigenesis in APC1638N Mice Later in Life

Nutrients. 2024 Jul 25;16(15):2408. doi: 10.3390/nu16152408.

Abstract

Young-onset colorectal cancer is an increasing concern worldwide due to the growing prevalence of Westernized lifestyles in childhood and adolescence. Environmental factors during early life, particularly early-life nutrition, significantly contribute to the increasing incidence. Recently, there have been reports of beneficial effects, including anti-inflammation and anti-cancer, of a unique fungus (Antrodia camphorate, AC) native to Taiwan. The objective of this study is to investigate the impact of AC supplementation in early life on the development of young-onset intestinal tumorigenesis. APC1638N mice were fed with a high-fat diet (HF) at 4-12 weeks of age, which is equivalent to human childhood/adolescence, before switching to a normal maintenance diet for an additional 12 weeks up to 24 weeks of age, which is equivalent to young to middle adulthood in humans. Our results showed that the body weight in the HF groups significantly increased after 8 weeks of feeding (p < 0.05). Following a switch to a normal maintenance diet, the change in body weight persisted. AC supplementation significantly suppressed tumor incidence and multiplicity in females (p < 0.05) and reduced IGF-1 and Wnt/β-catenin signaling (p < 0.05). Moreover, it altered the gut microbiota, suppressed inflammatory responses, and created a microenvironment towards suppressing tumorigenesis later in life.

Keywords: Antrodia camphorate; IGF-1/MAPK/ERK signaling; Wnt/β-catenin signaling; early-life nutrition; microbiota; young-onset colorectal cancer.

MeSH terms

  • Adenomatous Polyposis Coli Protein / genetics
  • Animals
  • Carcinogenesis* / drug effects
  • Colorectal Neoplasms / prevention & control
  • Diet, High-Fat* / adverse effects
  • Dietary Supplements*
  • Disease Models, Animal
  • Female
  • Gastrointestinal Microbiome* / drug effects
  • Insulin-Like Growth Factor I / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Polyporales
  • Wnt Signaling Pathway / drug effects

Substances

  • Insulin-Like Growth Factor I
  • Adenomatous Polyposis Coli Protein

Supplementary concepts

  • Taiwanofungus camphoratus